| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,402 | 67,682 | 53,884 | 53,782 | | Cost of Revenue | 7,445 | 8,441 | 8,407 | 9,963 | | | Gross Profit |
-
| 59,241 | 45,477 | 43,819 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,356 | 35,713 | 26,769 | 24,788 | | Non Recurring | 1,947 | 10,844 | 1,538 |
-
| | Others | 2,790 | 6,121 | 4,000 | 12,025 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,563 | 13,170 | 7,006 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 13,864 | 6,563 | 13,170 | 7,006 | | Interest Expense | 5,237 | 5,265 | 5,015 | 5,024 | | Income Before Tax | 8,627 | 1,298 | 8,155 | 1,982 | | Income Tax Expense | 1,786 | 639 | 1,767 | (1,039) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,841 | 659 | 6,388 | 3,021 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,841 | 659 | 6,388 | 3,021 | | Preferred Stock And Other Adjustments |
-
| (4,525) | (1,173) |
-
| | | Net Income Applicable To Common Shares | $6,841 | ($3,866) | $5,215 | $3,021 |
|
0.02% Nasdaq 0.00%
Income Statement
